for a highly selective and potentially best-in-class small molecule targeting a broad range of cancers,” Menarini CEO Elcin Barker Ergun said in a statement. “This asset will help us enter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback